Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 162
- −4 vs. Q2 2024
- Portfolio value
- $6.17B
- +$18.1M (+0.3%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TEMTempus AI, Inc. | CL A | 516 | $29.2K | <0.1% | −4,484−89.7% | Reduced | History |
| LHLabcorp Holdings Inc. | Stock | 206 | $46.0K | <0.1% | +16+8.4% | Added | History |
| OABIOmniAb, Inc. | COM | 11,456 | $48.5K | <0.1% | 00.0% | Unchanged | History |
| MTDMettler Toledo International Inc | COM | 41 | $61.5K | <0.1% | +1+2.5% | Added | History |
| QCOMQualcomm Inc | Stock | 427 | $72.6K | <0.1% | +36+9.2% | Added | History |
| MSFTMicrosoft Corp | Stock | 194 | $83.5K | <0.1% | +15+8.4% | Added | History |
| NVDANVIDIA Corp | Stock | 716 | $87.0K | <0.1% | +61+9.3% | Added | History |
| ORCLOracle Corp | Stock | 624 | $106.3K | <0.1% | +53+9.3% | Added | History |
| AAgilent Technologies, Inc. | COM | 769 | $114.2K | <0.1% | +65+9.2% | Added | History |
| VCYTVeracyte, Inc. | COM | 3,600 | $122.5K | <0.1% | +3,600 | New | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 7,700 | $127.8K | <0.1% | +7,700 | New | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 41,500 | $150.6K | <0.1% | +9,000+27.7% | Added | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 9,300 | $171.8K | <0.1% | −10,400−52.8% | Reduced | History |
| NRIXNurix Therapeutics, Inc. | COM | 8,000 | $179.8K | <0.1% | +8,000 | New | History |
| GRMNGarmin Ltd | SHS | 1,050 | $184.8K | <0.1% | 00.0% | Unchanged | History |
| MLYSMineralys Therapeutics, Inc. | COM | 16,499 | $199.8K | <0.1% | −1,000−5.7% | Reduced | History |
| BIDUBaidu, Inc. | ADR | 2,000 | $210.6K | <0.1% | 00.0% | Unchanged | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 4,400 | $221.8K | <0.1% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 4,000 | $222.2K | <0.1% | 00.0% | Unchanged | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 7,200 | $228.1K | <0.1% | +1,500+26.3% | Added | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 1,100 | $233.4K | <0.1% | 00.0% | Unchanged | History |
| BBIOBridgeBio Pharma, Inc. | COM | 10,400 | $264.8K | <0.1% | −2,400−18.8% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 13,600 | $265.7K | <0.1% | +3,600+36.0% | Added | History |
| BPMCBlueprint Medicines Corp | COM | 3,200 | $296.0K | <0.1% | −1,900−37.3% | Reduced | History |
| NKENIKE, Inc. | Stock | 3,500 | $309.4K | <0.1% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 8,200 | $322.8K | <0.1% | −2,000−19.6% | Reduced | History |
| ACLXArcellx, Inc. | COMMON STOCK | 4,000 | $334.0K | <0.1% | +4,000 | New | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 39,500 | $367.4K | <0.1% | +22,000+125.7% | Added | History |
| MRUSMerus N.V. | COM | 8,000 | $399.7K | <0.1% | −1,800−18.4% | Reduced | History |
| TVTXTravere Therapeutics, Inc. | COM | 31,000 | $433.7K | <0.1% | +31,000 | New | History |
| VTRSViatris Inc | Stock | 39,283 | $456.1K | <0.1% | +12,752+48.1% | Added | History |
| DNLIDenali Therapeutics Inc. | COM | 15,700 | $457.3K | <0.1% | +15,700 | New | History |
| HCMHUTCHMED (China) Ltd | SPONSORED ADS | 24,015 | $469.0K | <0.1% | −1,125,142−97.9% | Reduced | History |
| BIIBBiogen Inc. | COM | 2,634 | $510.6K | <0.1% | −3,268−55.4% | Reduced | History |
| ADMAAdma Biologics, Inc. | COM | 25,900 | $517.7K | <0.1% | −5,000−16.2% | Reduced | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 19,046 | $549.3K | <0.1% | −425,358−95.7% | Reduced | History |
| PTGXProtagonist Therapeutics, Inc | COM | 12,346 | $555.6K | <0.1% | −2,800−18.5% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 10,941 | $577.7K | <0.1% | −5,718−34.3% | Reduced | History |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 76,414 | $635.8K | <0.1% | +13,654+21.8% | Added | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 15,700 | $822.5K | <0.1% | +2,700+20.8% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 4,779 | $869.9K | <0.1% | +581+13.8% | Added | History |
| SNYSanofi | SPONSORED ADR | 15,109 | $870.7K | <0.1% | +15,109 | New | History |
| THCTenet Healthcare Corp | COM NEW | 5,625 | $934.9K | <0.1% | +211+3.9% | Added | History |
| GOOGAlphabet Inc. | Stock | 6,000 | $1.00M | <0.1% | 00.0% | Unchanged | History |
| VKTXViking Therapeutics, Inc. | COM | 16,179 | $1.02M | <0.1% | +11,779+267.7% | Added | History |
| ZTSZoetis Inc. | Stock | 5,284 | $1.03M | <0.1% | +2,343+79.7% | Added | History |
| BNTXBioNTech SE | SPONSORED ADS | 8,721 | $1.04M | <0.1% | +8,721 | New | History |
| CERTCertara, Inc. | COM | 95,924 | $1.12M | <0.1% | 00.0% | Unchanged | History |
| DOCSDoximity, Inc. | CL A | 29,060 | $1.27M | <0.1% | −43,095−59.7% | Reduced | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 70,821 | $1.28M | <0.1% | −83,949−54.2% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 11,981 | $1.37M | <0.1% | −2,229−15.7% | Reduced | History |
| CVSCVS Health Corp | Stock | 22,066 | $1.39M | <0.1% | 00.0% | Unchanged | History |
| SMMTSummit Therapeutics Inc. | COM | 64,094 | $1.40M | <0.1% | +64,094 | New | History |
| RDYDr Reddys Laboratories Ltd | ADR | 20,595 | $1.64M | <0.1% | −2,733−11.7% | Reduced | History |
| MTEMMolecular Templates, Inc. | COM NEW | 1,279,820 | $1.80M | <0.1% | 00.0% | Unchanged | History |
| EHCEncompass Health Corp | COM | 19,233 | $1.86M | <0.1% | +5,365+38.7% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 36,825 | $1.91M | <0.1% | +36,825 | New | History |
| ACCDAccolade, Inc. | COM | 640,865 | $2.47M | <0.1% | −201,712−23.9% | Reduced | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 392,881 | $2.59M | <0.1% | −32,929−7.7% | Reduced | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 33,500 | $2.61M | <0.1% | −8,700−20.6% | Reduced | History |
| CAHCardinal Health Inc | Stock | 30,224 | $3.34M | 0.1% | −2,358−7.2% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 46,027 | $3.86M | 0.1% | +7,093+18.2% | Added | History |
| PFEPfizer Inc | Stock | 141,075 | $4.08M | 0.1% | +52,461+59.2% | Added | History |
| WAYWaystar Holding Corp. | COM | 150,202 | $4.19M | 0.1% | +202+0.1% | Added | History |
| MRKMerck & Co., Inc. | Stock | 42,233 | $4.80M | 0.1% | −32,476−43.5% | Reduced | History |
| ALTAltimmune, Inc. | COM NEW | 863,660 | $5.30M | 0.1% | +263,660+43.9% | Added | History |
| ILMNIllumina, Inc. | COM | 45,196 | $5.89M | 0.1% | +1,600+3.7% | Added | History |
| TXG10x Genomics, Inc. | CL A COM | 281,881 | $6.36M | 0.1% | −26,430−8.6% | Reduced | History |
| CNCCentene Corp | Stock | 86,708 | $6.53M | 0.1% | −334,750−79.4% | Reduced | History |
| AMGNAmgen Inc | Stock | 25,152 | $8.10M | 0.1% | −4,376−14.8% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 62,983 | $8.21M | 0.1% | +7,057+12.6% | Added | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 169,134 | $8.24M | 0.1% | −200,136−54.2% | Reduced | History |
| JNJJohnson & Johnson | Stock | 51,242 | $8.30M | 0.1% | +43,445+557.2% | Added | History |
| ABBVAbbVie Inc. | Stock | 42,886 | $8.47M | 0.1% | +682+1.6% | Added | History |
| OMCLOmnicell, Inc. | COM | 197,714 | $8.62M | 0.1% | −37,658−16.0% | Reduced | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,042,135 | $8.69M | 0.1% | +1,042,135 | New | History |
| HUMHumana Inc | Stock | 28,440 | $9.01M | 0.1% | 00.0% | Unchanged | History |
| PHRPhreesia, Inc. | COM | 422,406 | $9.63M | 0.2% | −20,935−4.7% | Reduced | History |
| GBIOGeneration Bio Co. | COM | 3,918,856 | $9.68M | 0.2% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 58,729 | $13.2M | 0.2% | +33,100+129.2% | Added | History |
| CRLCharles River Laboratories International, Inc. | COM | 73,115 | $14.4M | 0.2% | −159,587−68.6% | Reduced | History |
| ASTHAstrana Health, Inc. | COM NEW | 254,182 | $14.7M | 0.2% | +3,565+1.4% | Added | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 46,151 | $15.4M | 0.3% | −109,107−70.3% | Reduced | History |
| CORCencora, Inc. | Stock | 72,053 | $16.2M | 0.3% | −17,276−19.3% | Reduced | History |
| ESPREsperion Therapeutics, Inc. | COM | 9,944,064 | $16.4M | 0.3% | 00.0% | Unchanged | History |
| FATEFate Therapeutics Inc | COM | 4,839,779 | $16.9M | 0.3% | 00.0% | Unchanged | History |
| SRRKScholar Rock Holding Corp | COM | 2,161,203 | $17.3M | 0.3% | −4,000−0.2% | Reduced | History |
| NTRANatera, Inc. | COM | 138,459 | $17.6M | 0.3% | −75,528−35.3% | Reduced | History |
| MCKMcKesson Corp | Stock | 35,742 | $17.7M | 0.3% | −10,400−22.5% | Reduced | History |
| PRVAPrivia Health Group, Inc. | COM | 1,059,171 | $19.3M | 0.3% | 00.0% | Unchanged | History |
| SIBNSI-BONE, Inc. | COM | 1,444,109 | $20.2M | 0.3% | +56,500+4.1% | Added | History |
| HOLXHologic Inc | COM | 247,864 | $20.2M | 0.3% | +380.0% | Added | History |
| STESTERIS plc | SHS USD | 91,282 | $22.1M | 0.4% | 00.0% | Unchanged | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 330,976 | $23.3M | 0.4% | +278,744+533.7% | Added | History |
| MOHMolina Healthcare, Inc. | COM | 67,562 | $23.3M | 0.4% | −8,831−11.6% | Reduced | History |
| NEONeogenomics Inc | COM NEW | 1,612,612 | $23.8M | 0.4% | +410,516+34.2% | Added | History |
| TMDXTransMedics Group, Inc. | COM | 169,844 | $26.7M | 0.4% | −31,571−15.7% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 629,758 | $27.6M | 0.4% | +72,437+13.0% | Added | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 26,776 | $28.1M | 0.5% | −5,521−17.1% | Reduced | History |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 610,000 | $28.7M | 0.5% | −7,649−1.2% | Reduced | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Summit Therapeutics Inc86627T908 | CALL | – | $219.0K |
Sold out since Q2 2024 (15)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| SILKSilk Road Medical Inc | COM | 855,293 | $23.1M | 0.4% | History |
| ATRCAtriCure, Inc. | COM | 212,559 | $4.84M | 0.1% | History |
| OMOutset Medical, Inc. | COM | 762,799 | $2.94M | <0.1% | History |
| TDOCTeladoc Health, Inc. | COM | 272,798 | $2.67M | <0.1% | History |
| NVRONevro Corp | COM | 135,235 | $1.14M | <0.1% | History |
| AAPLApple Inc. | Stock | 2,200 | $463.4K | <0.1% | History |
| ALKSAlkermes plc. | SHS | 18,000 | $433.8K | <0.1% | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 15,700 | $329.5K | <0.1% | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 16,000 | $323.8K | <0.1% | History |
| DVAXDynavax Technologies Corp | COM NEW | 27,558 | $309.5K | <0.1% | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 57,600 | $266.1K | <0.1% | History |
| ETNB89bio, Inc. | COM | 24,700 | $197.8K | <0.1% | History |
| WSTWest Pharmaceutical Services Inc | COM | 520 | $171.3K | <0.1% | History |
| GRALGRAIL, Inc. | COM | 7,266 | $111.7K | <0.1% | History |
| Exscientia PLC30223G102 | ADS | 3,350 | $17.1K | <0.1% | – |